Anlon Healthcare Limited (NSE:AHCL)

India · Delayed Price · Currency is INR

15.59

+0.12 (0.78%)

At close: Jul 10, 2026

69.46% (1Y)

Market Cap	8.29B
Revenue (ttm)	1.72B +42.9%
Net Income	285.14M +39.0%
EPS	0.61 -4.0%
Shares Out	531.52M
PE Ratio	25.52
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,951,504
Open	15.64
Previous Close	15.47
Day's Range	15.50 - 15.72
52-Week Range	9.08 - 17.28
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 7, 2026

About Anlon Healthcare

Anlon Healthcare Limited manufactures and sells advance pharmaceutical intermediates in India and internationally. The company offers active pharmaceutical ingredients (API); nutraceutical API products; personal care ingredients; and veterinary API products. Its products are used in anti-inflammatory (NSAID), analgesic, antipyretic, antihistamine, antidepressant, antipsychotic, anticoagulant, antihypertensive, nutrition, anti-arrhythmic, anti-hyper parathyroid, antiplatelet, ant diabetic, gastroesophageal reflux disease (GERD), and anti-rheumat... [Read more]

Industry Medicinal Chemicals and Botanical Products

Founded 2013

Employees 117

Stock Exchange National Stock Exchange of India

Ticker Symbol AHCL

Full Company Profile

Financial Performance

In fiscal year 2026, Anlon Healthcare's revenue was 1.72 billion, an increase of 42.91% compared to the previous year's 1.20 billion. Earnings were 285.14 million, an increase of 38.97%.

Financial Statements